Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Melissa A. Davidson, Donald R. Mattison, Laurent Azoulay & Daniel Krewski. (2018) Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Critical Reviews in Toxicology 48:1, pages 52-108.
Read now
Read now
Kuan-Chung Chen, Su-Sen Chang, Hung-Jin Huang, Tu-Liang Lin, Yong-Jiang Wu & Calvin Yu-Chian Chen. (2012) Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine. Journal of Biomolecular Structure and Dynamics 30:6, pages 662-683.
Read now
Read now
Hung-Jin Huang, Kuei-Jen Lee, Hsin
Wei Yu, Hsin-Yi Chen, Fuu-Jen Tsai & Calvin
Yu-Chian Chen. (2010) A Novel Strategy for Designing the Selective PPAR Agonist by the “Sum of Activity” Model. Journal of Biomolecular Structure and Dynamics 28:2, pages 187-200.
Read now
Read now
Articles from other publishers (46)
Binggong Zhao, Zhiqiang Xin, Ping Ren & Huijian Wu. (2022) The Role of PPARs in Breast Cancer. Cells 12:1, pages 130.
Crossref
Crossref
Shivanand Pudakalakatti, Mark Titus, José S. Enriquez, Sumankalai Ramachandran, Niki M. Zacharias, Imad Shureiqi, Yi Liu, James C. Yao, Xiangsheng Zuo & Pratip K. Bhattacharya. (2022) Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors. International Journal of Molecular Sciences 23:3, pages 1645.
Crossref
Crossref
Donald J. AbrahamRalf Glatthar & Robert H. Arch. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
71
.
Donald J. AbrahamPeter T.W. Cheng, Ellen Kick & Ranjan Mukherjee. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
117
.
Mohammad Zarei, David Aguilar-Recarte, Xavier Palomer & Manuel Vázquez-Carrera. (2021) Revealing the role of peroxisome proliferator-activated receptor β/δ in nonalcoholic fatty liver disease. Metabolism 114, pages 154342.
Crossref
Crossref
Tara Man Kadayat, Aarajana Shrestha, Yong Hyun Jeon, Hongchan An, Jina Kim, Sung Jin Cho & Jungwook Chin. (2020) Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective. Journal of Medicinal Chemistry 63:18, pages 10109-10134.
Crossref
Crossref
Dong-Su Kim, Jaehwan Lee, Ashwini M. Londhe, Tara Man Kadayat, Jeongmin Joo, Hayoung Hwang, Kyung-Hee Kim, Ae Nim Pae, Jungwook Chin, Sung Jin Cho & Heonjoong Kang. (2018) Synthesis and evaluation of an orally available “Y”-shaped biaryl peroxisome proliferator-activated receptor δ agonist. Bioorganic & Medicinal Chemistry 26:15, pages 4382-4389.
Crossref
Crossref
Fan Hong, Pengfei Xu & Yonggong Zhai. (2018) The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development. International Journal of Molecular Sciences 19:8, pages 2189.
Crossref
Crossref
Xavier Palomer, Emma Barroso, Javier Pizarro-Delgado, Lucía Peña, Gaia Botteri, Mohammad Zarei, David Aguilar, Marta Montori-Grau & Manuel Vázquez-Carrera. (2018) PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders. International Journal of Molecular Sciences 19:3, pages 913.
Crossref
Crossref
Mario Thevis, Oliver Krug, Hans Geyer, Katja Walpurgis, Norbert Baume & Andreas Thomas. (2018) Analytical challenges in sports drug testing. Analytical and Bioanalytical Chemistry 410:9, pages 2275-2281.
Crossref
Crossref
Fahrettin Haczeyni, Hans Wang, Vanessa Barn, Auvro R. Mridha, Matthew M. Yeh, W. Geoffrey Haigh, George N. Ioannou, Yun‐Jung Choi, Charles A. McWherter, Narcissus C.‐H. Teoh & Geoffrey C. Farrell. (2017) The selective peroxisome proliferator–activated receptor‐delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice. Hepatology Communications 1:7, pages 663-674.
Crossref
Crossref
Kyeongkyu Kim, Kyungjin Boo, Young Suk Yu, Se Kyu Oh, Hyunkyung Kim, Yoon Jeon, Jinhyuk Bhin, Daehee Hwang, Keun Il Kim, Jun-Su Lee, Seung-Soon Im, Seul Gi Yoon, Il Yong Kim, Je Kyung Seong, Ho Lee, Sungsoon Fang & Sung Hee Baek. (2017) RORα controls hepatic lipid homeostasis via negative regulation of PPARγ transcriptional network. Nature Communications 8:1.
Crossref
Crossref
Shogo Okazaki, Ryuta Shioi, Tomomi Noguchi-Yachide, Minoru Ishikawa, Makoto Makishima, Yuichi Hashimoto & Takao Yamaguchi. (2016) Structure–activity relationship studies of non-carboxylic acid peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists. Bioorganic & Medicinal Chemistry 24:21, pages 5455-5461.
Crossref
Crossref
Xavier Palomer, Emma Barroso, Mohammad Zarei, Gaia Botteri & Manuel Vázquez-Carrera. (2016) PPARβ/δ and lipid metabolism in the heart. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1861:10, pages 1569-1578.
Crossref
Crossref
Manuel Vázquez-Carrera. (2016) Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease. Trends in Endocrinology & Metabolism 27:5, pages 319-334.
Crossref
Crossref
Hyo Jin Gim, Hua Li, Ji Hye Jeong, Su Jeong Lee, Mi-Kyung Sung, Mi-Young Song, Byung-Hyun Park, Soo Jin Oh, Jae-Ha Ryu & Raok Jeon. (2015) Design, synthesis, and biological evaluation of a series of alkoxy-3-indolylacetic acids as peroxisome proliferator-activated receptor γ/δ agonists. Bioorganic & Medicinal Chemistry 23:13, pages 3322-3336.
Crossref
Crossref
Till Adhikary, Annika Wortmann, Tim Schumann, Florian Finkernagel, Sonja Lieber, Katrin Roth, Philipp M. Toth, Wibke E. Diederich, Andrea Nist, Thorsten Stiewe, Lara Kleinesudeik, Silke Reinartz, Sabine Müller-Brüsselbach & Rolf Müller. (2015) The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state. Nucleic Acids Research 43:10, pages 5033-5051.
Crossref
Crossref
Wei Chen, Rong Gao, Xinni Xie, Zhibing Zheng, Haijing Li, Song Li, Fangting Dong & Lili Wang. (2015) A metabolomic study of the PPARδ agonist GW501516 for enhancing running endurance in Kunming mice. Scientific Reports 5:1.
Crossref
Crossref
Greta MP Giordano Attianese & Béatrice Desvergne. (2015) Integrative and Systemic Approaches for Evaluating PPARβ/δ (PPARD) Function. Nuclear Receptor Signaling 13:1, pages nrs.13001.
Crossref
Crossref
Nishika Sahini & Jürgen Borlak. (2014) Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Progress in Lipid Research 54, pages 86-112.
Crossref
Crossref
Suofu Qin, Yimin Lu & Gerard A. Rodrigues. (2014) Resveratrol protects RPE cells from sodium iodate by modulating PPAR? and PPAR?. Experimental Eye Research 118, pages 100-108.
Crossref
Crossref
Simona D’Amore, Giuseppe Palasciano & Antonio Moschetta. 2014. A Systems Biology Approach to Study Metabolic Syndrome. A Systems Biology Approach to Study Metabolic Syndrome
27
61
.
Alessandra Ammazzalorso, Barbara De Filippis, Letizia Giampietro & Rosa Amoroso. (2013) Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview. ChemMedChem, pages n/a-n/a.
Crossref
Crossref
Liraz Levi, Glenn Lobo, Mary Kathryn Doud, Johannes von Lintig, Darcie Seachrist, Gregory P. Tochtrop & Noa Noy. (2013) Genetic Ablation of the Fatty Acid–Binding Protein FABP5 Suppresses HER2-Induced Mammary Tumorigenesis. Cancer Research 73:15, pages 4770-4780.
Crossref
Crossref
Vin?cius Gon?alves Maltarollo & K?thia Maria Hon?rio. (2012) Molecular properties of fatty acids related to PPAR binding and metabolic diseases. Medicinal Chemistry Research 22:7, pages 3126-3133.
Crossref
Crossref
Paola Dongiovanni & Luca Valenti. (2013) Peroxisome Proliferator-Activated Receptor Genetic Polymorphisms and Nonalcoholic Fatty Liver Disease: Any Role in Disease Susceptibility?. PPAR Research 2013, pages 1-8.
Crossref
Crossref
Combiz Khozoie, Michael G Borland, Bokai Zhu, Songjoon Baek, Sam John, Gordon L Hager, Yatrik M Shah, Frank J Gonzalez & Jeffrey M Peters. (2012) Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4. BMC Genomics 13:1.
Crossref
Crossref
Vin?cius G. Maltarollo & K?thia M. Hon?rio. (2012) Ligand- and Structure-Based Drug Design Strategies and PPAR?/? Selectivity. Chemical Biology & Drug Design 80:4, pages 533-544.
Crossref
Crossref
Michael A. Pearen & George E. O. Muscat. (2012) Orphan Nuclear Receptors and the Regulation of Nutrient Metabolism: Understanding Obesity. Physiology 27:3, pages 156-166.
Crossref
Crossref
Jeffrey M. Peters, Jose L. Morales & Frank J. Gonzalez. (2011) Modulation of gastrointestinal inflammation and colorectal tumorigenesis by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ). Drug Discovery Today: Disease Mechanisms 8:3-4, pages e85-e93.
Crossref
Crossref
Simone Naruhn, Philipp M. Toth, Till Adhikary, Kerstin Kaddatz, Veronika Pape, Stefanie Dörr, Gerhard Klebe, Sabine Müller-Brüsselbach, Wibke E. Diederich & Rolf Müller. (2011) High-Affinity Peroxisome Proliferator-Activated Receptor β/δ-Specific Ligands with Pure Antagonistic or Inverse Agonistic Properties. Molecular Pharmacology 80:5, pages 828-838.
Crossref
Crossref
Michele Vacca, Chiara Degirolamo, Renato Mariani‐Costantini, Giuseppe Palasciano & Antonio Moschetta. (2011) Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. WIREs Systems Biology and Medicine 3:5, pages 562-587.
Crossref
Crossref
C. J. Omiecinski, J. P. Vanden Heuvel, G. H. Perdew & J. M. Peters. (2010) Xenobiotic Metabolism, Disposition, and Regulation by Receptors: From Biochemical Phenomenon to Predictors of Major Toxicities. Toxicological Sciences 120:Supplement 1, pages S49-S75.
Crossref
Crossref
Markus Meissner, Igor Hrgovic, Monika Doll & Roland Kaufmann. (2010) PPARδ agonists suppress angiogenesis in a VEGFR2-dependent manner. Archives of Dermatological Research 303:1, pages 41-47.
Crossref
Crossref
Jonathan R. S. Arch. 2011. Diabetes - Perspectives in Drug Therapy. Diabetes - Perspectives in Drug Therapy
201
255
.
Muralimohan Yepuru, Jeetendra Eswaraka, Jeffrey D. Kearbey, Christina M. Barrett, Sharan Raghow, Karen A. Veverka, Duane D. Miller, James T. Dalton & Ramesh Narayanan. (2010) Estrogen Receptor-β-selective Ligands Alleviate High-fat Diet- and Ovariectomy-induced Obesity in Mice. Journal of Biological Chemistry 285:41, pages 31292-31303.
Crossref
Crossref
Ira G. Schulman. (2010) Nuclear receptors as drug targets for metabolic disease. Advanced Drug Delivery Reviews 62:13, pages 1307-1315.
Crossref
Crossref
Donald J. AbrahamPeter T.W. Cheng, Ellen Kick & Ranjan Mukherjee. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
77
188
.
Prajakta S. Palkar, Michael G. Borland, Simone Naruhn, Christina H. Ferry, Christina Lee, Ugir H. Sk, Arun K. Sharma, Shantu Amin, Iain A. Murray, Cherie R. Anderson, Gary H. Perdew, Frank J. Gonzalez, Rolf Müller & Jeffrey M. Peters. (2010) Cellular and Pharmacological Selectivity of the Peroxisome Proliferator-Activated Receptor-β/δ Antagonist GSK3787. Molecular Pharmacology 78:3, pages 419-430.
Crossref
Crossref
Petra Arck, Bettina Toth, Aurelia Pestka & Udo Jeschke. (2010) Nuclear Receptors of the Peroxisome Proliferator-Activated Receptor (PPAR) Family in Gestational Diabetes: From Animal Models to Clinical Trials1. Biology of Reproduction 83:2, pages 168-176.
Crossref
Crossref
Matthew A. Cavender, Stephen J. Nicholls & Lincoff A. Michael. (2010) Strategies for the development of new PPAR agonists in diabetes. European Journal of Cardiovascular Prevention & Rehabilitation 17:1_suppl, pages s32-s37.
Crossref
Crossref
Tommaso Mello. (2010) Nuclear Receptors in the Regulation of Lipid Metabolism. Current Cardiovascular Risk Reports 4:2, pages 142-149.
Crossref
Crossref
David Bishop-Bailey & Jonas Bystrom. (2009) Emerging roles of peroxisome proliferator-activated receptor-β/δ in inflammation. Pharmacology & Therapeutics 124:2, pages 141-150.
Crossref
Crossref
Ewa Ehrenborg & Anna Krook. (2009) Regulation of Skeletal Muscle Physiology and Metabolism by Peroxisome Proliferator-Activated Receptor δ. Pharmacological Reviews 61:3, pages 373-393.
Crossref
Crossref
Anna Leonardini, Luigi Laviola, Sebastio Perrini, Annalisa Natalicchio & Francesco Giorgino. (2009)
Cross-Talk between PPAR
and Insulin Signaling and Modulation of Insulin Sensitivity
. PPAR Research 2009, pages 1-12.
Crossref
Crossref
Francine M. Gregoire. (2008)
Peroxisome Proliferator-Activated Receptor
: A Target with a Broad Therapeutic Potential for Drug Discovery
. PPAR Research 2008, pages 1-2.
Crossref
Crossref